Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.352 Factor de Impacto de 5 años: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v37.i2-6.120
pages 463-487

Lymphocyte Activation in Health and Disease

Michael J. Berridge
The Babraham Institute Laboratory of Molecular Signalling, P. O. Box 158, Cambridge CB2 3ES, U.K.


Lymphocytes employ a complex assembly of signaling elements that have been organized on a spatiotemporal map to define their role in stimulating both proliferation and apoptosis. The antigen/major histocompatibility complex (MHC) initiates the sequence by organizing the assembly of an active T-cell receptor (TCR) complex responsible for transmitting information down various signaling cassettes (e.g., the IP3/Ca2+, DAG/ PKC, ras/MAPK, and the PI 3-K pathways). It is proposed that CD28 may exert its costimulatory action by facilitating the assembly of an effective scaffold of signaling elements within the TCR complex. The absence of costimulation through CD28 seems to result in the assembly of a defective scaffold that reverses slowly and may thus account for the state of unresponsiveness responsible for peripheral T-cell tolerance. The signaling cassettes activated by the TCR and CD28 then engage cytosolic factors that transmit information into the nucleus to activate the genes that code for the IL-2 and Fas signaling pathways. The IL-2 and Fas receptors employ additional signaling cassettes (e.g., the JAK/STAT and the sphingomyelinase/ceramide pathways) to mediate their effects on proliferation and apoptosis, respectively. Information concerning these signaling systems is beginning to provide therapeutic strategies to manipulate the immune system to overcome human immunodeficiency virus (HIV) infection, autoimmune diseases, and graft rejection.

Articles with similar content:

Lymphocyte Activation in Health and Disease
Critical Reviews™ in Immunology, Vol.17, 1997, issue 2
Michael J. Berridge
CD5 as a Target for Immune-Based Therapies
Critical Reviews™ in Immunology, Vol.35, 2015, issue 2
Fernando Aranda, Marc Orta, Ines Simoes, Marta Consuegra-Fernandez, Francisco Lozano, Adelaida Sarukhan
NK Cells in Therapy of Cancer
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 1-2
Veronika Bachanova, Jeffrey S. Miller
Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells
Critical Reviews™ in Immunology, Vol.36, 2016, issue 2
Gang Zhou, Zhi-Chun Ding, Michal Kuczma
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
Critical Reviews™ in Immunology, Vol.33, 2013, issue 4
Alexander J. Gill , Dennis L. Kolson